Localized drug delivery represents one of the most challenging uses of systems based on conductive polymer films. Typically, anionic drugs are incorporated within conductive polymers through electrostatic interaction with the positively charged polymer. Following this approach, the synthetic glucocorticoid dexamethasone phosphate is often delivered from neural probes to reduce the inflammation of the surrounding tissue. In light of the recent literature on the neuroprotective and anti-inflammatory properties of tauroursodeoxycholic acid (TUDCA), for the first time, this natural bile acid was incorporated within poly(3,4-ethylenedioxythiophene) (PEDOT). The new material, PEDOT—TUDCA, efficiently promoted an electrochemically controlled delivery of the drug, while preserving optimal electrochemical properties. Moreover, the low cytotoxicity observed with viability assays, makes PEDOT–TUDCA a good candidate for prolonging the time span of chronic neural recording brain implants.

A New Drug Delivery System Based on Tauroursodeoxycholic Acid and PEDOT

Carli S
Primo
;
FIORAVANTI, GIULIA
Secondo
;
Ciarpella F;Prato M;Salerno M;Perrone D;Marchesi E;Fadiga L
Ultimo
2019

Abstract

Localized drug delivery represents one of the most challenging uses of systems based on conductive polymer films. Typically, anionic drugs are incorporated within conductive polymers through electrostatic interaction with the positively charged polymer. Following this approach, the synthetic glucocorticoid dexamethasone phosphate is often delivered from neural probes to reduce the inflammation of the surrounding tissue. In light of the recent literature on the neuroprotective and anti-inflammatory properties of tauroursodeoxycholic acid (TUDCA), for the first time, this natural bile acid was incorporated within poly(3,4-ethylenedioxythiophene) (PEDOT). The new material, PEDOT—TUDCA, efficiently promoted an electrochemically controlled delivery of the drug, while preserving optimal electrochemical properties. Moreover, the low cytotoxicity observed with viability assays, makes PEDOT–TUDCA a good candidate for prolonging the time span of chronic neural recording brain implants.
2019
Carli, S; Fioravanti, Giulia; Armirotti, A; Ciarpella, F; Prato, M; Ottonello, G; Salerno, M; Scarpellini, A; Perrone, D; Marchesi, E; Ricci, D; Fadiga, L
File in questo prodotto:
File Dimensione Formato  
33862490fc1402f45ed665a14d252c26.pdf

accesso aperto

Descrizione: post print
Tipologia: Post-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 5.45 MB
Formato Adobe PDF
5.45 MB Adobe PDF Visualizza/Apri
tudca1.pdf

accesso aperto

Descrizione: pre print
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 845.96 kB
Formato Adobe PDF
845.96 kB Adobe PDF Visualizza/Apri
chem.201805285.pdf

solo gestori archivio

Descrizione: editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.02 MB
Formato Adobe PDF
2.02 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2401138
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 21
social impact